Effects of 3-isobutyl-1-methylxanthine and cyclic nucleotides on the biochemical processes linked to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology*; D000287:Administration, Topical; D000818:Animals; D003043:Cocarcinogenesis; D000242:Cyclic AMP / Q000494:pharmacology*; D006152:Cyclic GMP / Q000494:pharmacology*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D005260:Female; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009955:Ornithine Decarboxylase / Q000378:metabolism; D010212:Papilloma / Q000139:chemically induced; D010704:Phorbols / Q000494:pharmacology*; D012878:Skin Neoplasms / Q000139:chemically induced*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D013806:Theophylline / Q000031:analogs & derivatives*
D004273:DNA, Neoplasm; D010704:Phorbols; D013806:Theophylline; D000242:Cyclic AMP; D009955:Ornithine Decarboxylase; D006152:Cyclic GMP; D013755:Tetradecanoylphorbol Acetate; D015056:1-Methyl-3-isobutylxanthine